ID   PPIG_HUMAN              Reviewed;         754 AA.
AC   Q13427; D3DPC5; D3DPC6; O00706; Q53R40; Q53SN4; Q96DG9;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   15-MAR-2017, entry version 156.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase G;
DE            Short=PPIase G;
DE            Short=Peptidyl-prolyl isomerase G;
DE            EC=5.2.1.8;
DE   AltName: Full=CASP10;
DE   AltName: Full=Clk-associating RS-cyclophilin;
DE            Short=CARS-Cyp;
DE            Short=CARS-cyclophilin;
DE            Short=SR-cyclophilin;
DE            Short=SR-cyp;
DE            Short=SRcyp;
DE   AltName: Full=Cyclophilin G;
DE   AltName: Full=Rotamase G;
GN   Name=PPIG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ASP-699.
RC   TISSUE=T-cell;
RX   PubMed=8973360; DOI=10.1016/S0378-1119(96)00436-2;
RA   Nestel F.P., Colwill K., Harper S., Pawson T., Anderson S.K.;
RT   "RS cyclophilins: identification of an NK-TR1-related cyclophilin.";
RL   Gene 180:151-155(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH CLK1 AND RNA
RP   POLYMERASE II, AND VARIANT ASP-699.
RC   TISSUE=B-cell;
RX   PubMed=9153302; DOI=10.1093/nar/25.11.2055;
RA   Bourquin J.-P., Stagljar I., Meier P., Moosmann P., Silke J.,
RA   Baechi T., Georgiev O., Schaffner W.;
RT   "A serine/arginine-rich nuclear matrix cyclophilin interacts with the
RT   C-terminal domain of RNA polymerase II.";
RL   Nucleic Acids Res. 25:2055-2061(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH PNN, AND SUBCELLULAR LOCATION.
RX   PubMed=15358154; DOI=10.1016/j.bbrc.2004.07.013;
RA   Lin C.L., Leu S., Lu M.C., Ouyang P.;
RT   "Over-expression of SR-cyclophilin, an interaction partner of nuclear
RT   pinin, releases SR family splicing factors from nuclear speckles.";
RL   Biochem. Biophys. Res. Commun. 321:638-647(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; THR-358 AND
RP   SER-687, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315 AND SER-696, VARIANT
RP   [LARGE SCALE ANALYSIS] ASP-699, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-254; SER-256; SER-257;
RP   SER-259; SER-397 AND SER-687, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-413; SER-415; SER-687;
RP   SER-690; SER-696; THR-748 AND SER-753, VARIANT [LARGE SCALE ANALYSIS]
RP   ASP-699, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; THR-358; SER-687;
RP   SER-690 AND THR-748, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; THR-358; SER-386;
RP   SER-397; SER-687; SER-745 AND THR-748, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-290; SER-744; SER-745
RP   AND THR-748, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes
CC       the cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides. May be implicated in the folding, transport, and
CC       assembly of proteins. May play an important role in the regulation
CC       of pre-mRNA splicing.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- ENZYME REGULATION: Cyclosporin A (CsA)-sensitive.
CC   -!- SUBUNIT: Interacts with CLK1, PNN and with the phosphorylated C-
CC       terminal domain of RNA polymerase II.
CC       {ECO:0000269|PubMed:15358154, ECO:0000269|PubMed:9153302}.
CC   -!- INTERACTION:
CC       Q8N7W2-2:BEND7; NbExp=3; IntAct=EBI-396072, EBI-10181188;
CC       Q8NHQ1:CEP70; NbExp=3; IntAct=EBI-396072, EBI-739624;
CC       O75553:DAB1; NbExp=3; IntAct=EBI-396072, EBI-7875264;
CC       Q9UI36-2:DACH1; NbExp=3; IntAct=EBI-396072, EBI-10186082;
CC       Q96C98:FHL3; NbExp=3; IntAct=EBI-396072, EBI-10229248;
CC       Q8NC69:KCTD6; NbExp=3; IntAct=EBI-396072, EBI-2511344;
CC       P17931:LGALS3; NbExp=3; IntAct=EBI-396072, EBI-1170392;
CC       Q6NVH9:LGALS3; NbExp=3; IntAct=EBI-396072, EBI-10187804;
CC       Q15365:PCBP1; NbExp=2; IntAct=EBI-396072, EBI-946095;
CC       Q9UL42:PNMA2; NbExp=3; IntAct=EBI-396072, EBI-302355;
CC       Q96CD2:PPCDC; NbExp=3; IntAct=EBI-396072, EBI-724333;
CC       Q14498:RBM39; NbExp=3; IntAct=EBI-396072, EBI-395290;
CC       Q16637:SMN2; NbExp=4; IntAct=EBI-396072, EBI-395421;
CC       Q12800:TFCP2; NbExp=3; IntAct=EBI-396072, EBI-717422;
CC       Q9NVV9:THAP1; NbExp=3; IntAct=EBI-396072, EBI-741515;
CC   -!- SUBCELLULAR LOCATION: Nucleus matrix
CC       {ECO:0000269|PubMed:15358154}. Nucleus speckle
CC       {ECO:0000269|PubMed:15358154}. Note=Colocalizes with RNA splicing
CC       factors at nuclear speckles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13427-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13427-2; Sequence=VSP_009662, VSP_009663;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: The RS domain is required for the interaction with the
CC       phosphorylated C-terminal domain of RNA polymerase II.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U40763; AAB40347.1; -; mRNA.
DR   EMBL; X99717; CAA68053.1; -; mRNA.
DR   EMBL; AC093899; AAY24119.1; -; Genomic_DNA.
DR   EMBL; AC016772; AAY24233.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11267.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11268.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11269.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11270.1; -; Genomic_DNA.
DR   EMBL; BC001555; AAH01555.1; -; mRNA.
DR   CCDS; CCDS2235.1; -. [Q13427-1]
DR   PIR; JC5314; JC5314.
DR   RefSeq; NP_004783.2; NM_004792.2. [Q13427-1]
DR   RefSeq; XP_005247023.1; XM_005246966.1. [Q13427-1]
DR   RefSeq; XP_005247024.1; XM_005246967.1. [Q13427-1]
DR   UniGene; Hs.470544; -.
DR   UniGene; Hs.593163; -.
DR   PDB; 2GW2; X-ray; 1.80 A; A=1-179.
DR   PDB; 2WFI; X-ray; 0.75 A; A=1-177.
DR   PDB; 2WFJ; X-ray; 0.75 A; A=1-177.
DR   PDBsum; 2GW2; -.
DR   PDBsum; 2WFI; -.
DR   PDBsum; 2WFJ; -.
DR   ProteinModelPortal; Q13427; -.
DR   SMR; Q13427; -.
DR   BioGrid; 114761; 45.
DR   IntAct; Q13427; 32.
DR   MINT; MINT-1684213; -.
DR   STRING; 9606.ENSP00000260970; -.
DR   BindingDB; Q13427; -.
DR   DrugBank; DB00172; L-Proline.
DR   iPTMnet; Q13427; -.
DR   PhosphoSitePlus; Q13427; -.
DR   BioMuta; PPIG; -.
DR   DMDM; 229462749; -.
DR   EPD; Q13427; -.
DR   MaxQB; Q13427; -.
DR   PaxDb; Q13427; -.
DR   PeptideAtlas; Q13427; -.
DR   PRIDE; Q13427; -.
DR   Ensembl; ENST00000260970; ENSP00000260970; ENSG00000138398. [Q13427-1]
DR   Ensembl; ENST00000448752; ENSP00000407083; ENSG00000138398. [Q13427-1]
DR   Ensembl; ENST00000462903; ENSP00000435987; ENSG00000138398. [Q13427-2]
DR   GeneID; 9360; -.
DR   KEGG; hsa:9360; -.
DR   UCSC; uc002uez.4; human. [Q13427-1]
DR   CTD; 9360; -.
DR   DisGeNET; 9360; -.
DR   GeneCards; PPIG; -.
DR   H-InvDB; HIX0029914; -.
DR   HGNC; HGNC:14650; PPIG.
DR   HPA; HPA021788; -.
DR   HPA; HPA057469; -.
DR   MIM; 606093; gene.
DR   neXtProt; NX_Q13427; -.
DR   OpenTargets; ENSG00000138398; -.
DR   PharmGKB; PA33585; -.
DR   eggNOG; KOG0546; Eukaryota.
DR   eggNOG; COG0652; LUCA.
DR   GeneTree; ENSGT00550000074595; -.
DR   HOVERGEN; HBG048162; -.
DR   InParanoid; Q13427; -.
DR   KO; K09566; -.
DR   OMA; KERDHET; -.
DR   OrthoDB; EOG091G0BGL; -.
DR   PhylomeDB; Q13427; -.
DR   TreeFam; TF318563; -.
DR   BRENDA; 5.2.1.8; 2681.
DR   ChiTaRS; PPIG; human.
DR   EvolutionaryTrace; Q13427; -.
DR   GeneWiki; PPIG_(gene); -.
DR   GenomeRNAi; 9360; -.
DR   PRO; PR:Q13427; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138398; -.
DR   CleanEx; HS_PPIG; -.
DR   ExpressionAtlas; Q13427; baseline and differential.
DR   Genevisible; Q13427; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016363; C:nuclear matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0016018; F:cyclosporin A binding; TAS:ProtInc.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Isomerase;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Rotamase.
FT   CHAIN         1    754       Peptidyl-prolyl cis-trans isomerase G.
FT                                /FTId=PRO_0000064150.
FT   DOMAIN       11    176       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   COMPBIAS    180    192       Arg/Lys-rich (basic).
FT   COMPBIAS    193    225       Asp/Glu/Ser-rich.
FT   COMPBIAS    193    208       Poly-Ser.
FT   COMPBIAS    226    253       Arg/Lys-rich (basic).
FT   COMPBIAS    540    639       Arg/Ser-rich (RS domain).
FT   COMPBIAS    621    626       Poly-Arg.
FT   MOD_RES     254    254       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     256    256       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     257    257       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     259    259       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     290    290       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     315    315       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     358    358       Phosphothreonine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     386    386       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     397    397       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     413    413       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     415    415       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES     687    687       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     690    690       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES     696    696       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     744    744       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     745    745       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     748    748       Phosphothreonine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     753    753       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ     340    357       RYRTPSRSRSRDRFRRSE -> VGDSFPRDLHNIAFVFLK
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009662.
FT   VAR_SEQ     358    754       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009663.
FT   VARIANT     445    445       D -> E (in dbSNP:rs1050354).
FT                                /FTId=VAR_055084.
FT   VARIANT     699    699       N -> D (in dbSNP:rs8207).
FT                                {ECO:0000244|PubMed:17525332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000269|PubMed:8973360,
FT                                ECO:0000269|PubMed:9153302}.
FT                                /FTId=VAR_055085.
FT   STRAND        9     16       {ECO:0000244|PDB:2WFI}.
FT   STRAND       19     28       {ECO:0000244|PDB:2WFI}.
FT   TURN         30     32       {ECO:0000244|PDB:2WFI}.
FT   HELIX        34     45       {ECO:0000244|PDB:2WFI}.
FT   TURN         46     48       {ECO:0000244|PDB:2WFJ}.
FT   TURN         52     54       {ECO:0000244|PDB:2WFI}.
FT   STRAND       56     58       {ECO:0000244|PDB:2WFI}.
FT   STRAND       64     69       {ECO:0000244|PDB:2WFI}.
FT   TURN         70     72       {ECO:0000244|PDB:2WFI}.
FT   STRAND       73     76       {ECO:0000244|PDB:2WFI}.
FT   TURN         79     81       {ECO:0000244|PDB:2WFI}.
FT   STRAND       82     85       {ECO:0000244|PDB:2WFI}.
FT   STRAND      109    112       {ECO:0000244|PDB:2WFI}.
FT   STRAND      114    116       {ECO:0000244|PDB:2WFJ}.
FT   STRAND      124    129       {ECO:0000244|PDB:2WFI}.
FT   HELIX       132    134       {ECO:0000244|PDB:2WFI}.
FT   TURN        135    137       {ECO:0000244|PDB:2WFI}.
FT   STRAND      140    146       {ECO:0000244|PDB:2WFI}.
FT   HELIX       148    155       {ECO:0000244|PDB:2WFI}.
FT   STRAND      165    167       {ECO:0000244|PDB:2WFI}.
FT   STRAND      169    176       {ECO:0000244|PDB:2WFI}.
SQ   SEQUENCE   754 AA;  88617 MW;  D4884808D8060CD6 CRC64;
     MGIKVQRPRC FFDIAINNQP AGRVVFELFS DVCPKTCENF RCLCTGEKGT GKSTQKPLHY
     KSCLFHRVVK DFMVQGGDFS EGNGRGGESI YGGFFEDESF AVKHNKEFLL SMANRGKDTN
     GSQFFITTKP TPHLDGHHVV FGQVISGQEV VREIENQKTD AASKPFAEVR ILSCGELIPK
     SKVKKEEKKR HKSSSSSSSS SSDSDSSSDS QSSSDSSDSE SATEEKSKKR KKKHRKNSRK
     HKKEKKKRKK SKKSASSESE AENLEAQPQS TVRPEEIPPI PENRFLMRKS PPKADEKERK
     NREREREREC NPPNSQPASY QRRLLVTRSG RKIKGRGPRR YRTPSRSRSR DRFRRSETPP
     HWRQEMQRAQ RMRVSSGERW IKGDKSELNE IKENQRSPVR VKERKITDHR NVSESPNRKN
     EKEKKVKDHK SNSKERDIRR NSEKDDKYKN KVKKRAKSKS RSKSKEKSKS KERDSKHNRN
     EEKRMRSRSK GRDHENVKEK EKQSDSKGKD QERSRSKEKS KQLESKSNEH DHSKSKEKDR
     RAQSRSRECD ITKGKHSYNS RTRERSRSRD RSRRVRSRTH DRDRSRSKEY HRYREQEYRR
     RGRSRSRERR TPPGRSRSKD RRRRRRDSRS SEREESQSRN KDKYRNQESK SSHRKENSES
     EKRMYSKSRD HNSSNNSREK KADRDQSPFS KIKQSSQDNE LKSSMLKNKE DEKIRSSVEK
     ENQKSKGQEN DHVHEKNKKF DHESSPGTDE DKSG
//
